Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer. - Wikidata - awgldk - TriplyDB

Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer.

Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer.

http://www.wikidata.org/entity/Q31155880

about

Targeting the estrogen pathway for the treatment and prevention of lung cancer EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data.Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients.Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer.Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing Lung adenocarcinoma harboring mutations in the ERBB2 kinase domain.Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB).Inactivation of LLC1 gene in nonsmall cell lung cancer Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients.Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States.Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3.Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled Analysis.The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck.Erlotinib in the treatment of non-small cell lung cancer.Molecular diagnostics of non-small cell lung cancer using mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration.Crossing the rubicon in lung adenocarcinoma: the conundrum of EGFR tyrosine kinase mutations.Cancer genes in lung cancer: racial disparities: are there any?Epidermal growth factor receptor inhibition and non-small cell lung cancer.Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers.A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer.Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma.Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.Epidermal growth factor receptor mutations in lung cancers.Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers Emerging ethnic differences in lung cancer therapy.Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist?Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays.Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research.Are there any differences in genomic characterization of non-small cell lung cancer between African Americans and Whites?Smoking out reproductive hormone actions in lung cancer.Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer.Estrongenic steroid hormones in lung cancer.Theme: oncology--molecular mechanisms determining the efficacy of EGF receptor-specific tyrosine kinase inhibitors help to identify biomarker candidates.Worldwide trend of increasing primary adenocarcinoma of the lung.Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.Personalized medicine: does the molecular suit fit?

P2860

Q28397456-862E358E-1988-4F16-84A3-45BD33457147 Q30915526-656CAACB-6AB3-4F33-9B6F-EDE7789D847C Q33290653-3CE8A18F-C58B-4FC3-816E-7974E5973DC8 Q33358603-06CA3057-B88F-499A-8771-9E2C999873B1 Q34673282-4A1F76DD-E319-4AAD-9CF3-B19EBB0AEE7E Q35671373-2E1F0EBC-42B1-4557-ADEC-3565C5AD7628 Q35790212-73CB2D4D-2FE8-4124-8C00-0FD85C37DF1E Q35854835-479F1738-D0B9-434C-85F9-546BA2511DF3 Q35870444-F60FE6AD-B289-4453-8F97-5A9548E5CC2C Q35898597-02D36F00-92D5-4471-9596-FEF529FE3C0C Q35915133-84A76550-1006-4480-A2F3-579888B684B4 Q35956330-61D3F3B9-5446-443F-A7B8-98040FFCFCE7 Q36050294-9D6C4BAA-6BA4-48A0-9194-CEF8CB51B241 Q36092880-B0403151-A571-4FA2-9A11-D1A72F9474ED Q36200850-098514BC-28E9-4945-BD6C-62E4296D09E1 Q36219713-C93DC85E-0B16-4604-AC61-C0EAE361EBDA Q36284485-179F3971-B43B-4B8C-B5C8-B080979E5DB4 Q36370600-B0677C97-6FDA-4A6D-B706-165B1425BE69 Q36429474-898B4A84-94B2-4E4A-A8FC-4950B7C45F88 Q36481954-22C215FD-908D-418E-8243-7528EBD9609B Q36504349-CA959735-6DFA-4AD6-A3F8-EB2096792F65 Q36608839-62ED8DE9-C721-4C62-B248-C44549840DE0 Q36614353-77D85C98-6623-4290-A43C-D8AC5381ABF0 Q36615150-48AE900E-0F6D-4614-A970-8E485A49FB95 Q36788485-2A39B1E8-4177-4237-8B5F-F831F6FD23D8 Q36817294-A4F57EC5-DCF0-4FFB-ABA9-8A1F0095A303 Q36905639-2DE0BC79-6470-43CA-AA7B-4886038318AD Q37010547-3AE8A896-0F8D-42F1-B541-16F7D473EA95 Q37110396-1C52689E-9E4D-431B-B88F-FA006FDE33D8 Q37175922-351DFEFF-7DAD-473E-8326-21989BE772BB Q37238134-3EF0516B-8B88-4F6F-9DF8-5F99CCA947D3 Q37528277-177D12EA-8543-4C37-8E2D-C14189D1F2E9 Q37679479-7F61E2A4-4C36-49F2-960D-BFC5C3AB9A7D Q37684483-7315CA35-8DBF-4931-BC88-64235E7506F3 Q37726987-D8C85622-E282-494A-9B25-7DA4D7D93D30 Q37755154-2BFD28B4-6B4F-4BC0-88A1-C605348455F7 Q38113540-D4F67B13-30F4-4505-A0CA-827578FA548F Q39476678-82F4A687-45C5-4F46-AF85-746D8C307FD2 Q40368173-4701EC30-C175-4059-833D-E2F57A95643C Q40885302-7C5A6A7E-1A4F-4326-A8BC-BEE3AC7BEBCB

P2860

Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer.

http://www.wikidata.org/entity/Q31155880

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Mutations in the tyrosine kina ...... in non-small cell lung cancer.

@ast

Mutations in the tyrosine kina ...... in non-small cell lung cancer.

@en

type

label

Mutations in the tyrosine kina ...... in non-small cell lung cancer.

@ast

Mutations in the tyrosine kina ...... in non-small cell lung cancer.

@en

prefLabel

Mutations in the tyrosine kina ...... in non-small cell lung cancer.

@ast

Mutations in the tyrosine kina ...... in non-small cell lung cancer.

@en

P1433

Q31155880-A11A5134-1225-4CE9-A337-7830CDE1CC5A

P1476

Q31155880-41A4C35A-DBCB-4040-A8A5-6350EC65D2C4

P2093

Q31155880-0C5A4BDB-B534-4712-B2DF-7638624E3531

Q31155880-1425A042-6BF0-403C-AFAB-4D44BF5357E9

Q31155880-2063B135-64A2-4FFC-93E7-14F39565462C

Q31155880-20E65D25-2CF4-415C-9133-23A67F7A91EF

Q31155880-64F4B83D-5FF2-4744-9B44-B7D091AFBD45

Q31155880-6AFACA21-1565-4F24-8488-2F3A0F1CE18B

Q31155880-71C153C2-D7FF-4FA3-9BEE-6F24733AF7DE

Q31155880-7B6963C9-0FAC-49CD-BBBF-131BA86A0C2B

Q31155880-7B77BC7D-0F94-4B2C-812A-3551804013D4

Q31155880-94B95548-8B01-4CED-AA91-043B62638931

P304

Q31155880-54547269-BFD4-45D0-A3BB-A1FC8335BF4A

P31

Q31155880-F4EE2802-F6DB-4479-8B98-C7DFD8A7C537

P356

Q31155880-0C7540B8-7564-4E32-90BC-F905B752FF6A

P407

Q31155880-EDD99D14-1A0C-4FA8-ACDC-12E3F11D890E

P433

Q31155880-26154E95-AD02-4E07-A68E-95CFCE90ED0A

P478

Q31155880-D1F26C74-719B-43AE-8735-999C975CAEEC

P577

Q31155880-CFA95F38-06B5-4F7B-B5F6-5F34B89BCC04

P698

Q31155880-B41AF855-24C1-4EE3-9382-9ECD7D8058BD

P356

1078-0432.CCR-04-1853

P1433

Clinical Cancer Research

P1476

Mutations in the tyrosine kina ...... in non-small cell lung cancer.

@en

P2093

Curtis C Harris

http://www.w3.org/2001/XMLSchema#string

Daoud Meerzaman

http://www.w3.org/2001/XMLSchema#string

Elise D Bowman

http://www.w3.org/2001/XMLSchema#string

Felicia Mann

http://www.w3.org/2001/XMLSchema#string

Jason Wampfler

http://www.w3.org/2001/XMLSchema#string

Jin Jen

http://www.w3.org/2001/XMLSchema#string

Junya Fukuoka

http://www.w3.org/2001/XMLSchema#string

Kyeong Man Hong

http://www.w3.org/2001/XMLSchema#string

Leah E Mechanic

http://www.w3.org/2001/XMLSchema#string

Maria Teresa Landi

http://www.w3.org/2001/XMLSchema#string

P304

2106-2110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-04-1853

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15788655

http://www.w3.org/2001/XMLSchema#string